Mountain View-based Complete Genomics, a provider of human genome sequencing services, said Friday that it has filed for an $86.25M IPO. The firm said it is looking to trade as GNOM on the Nasdaq. The IPO is being underwritten by UBS Investment Bank, Jefferies & Company, Baird, and Cowen and Company. The firm is venture backed Essex Woodlands Health Ventures, OrbiMed Advisors, Enterprise Partners Venture Capital, OVP Venture Partners, Prospect Venture Partners and Highland Capital Management. The firm reported revenues of $336,000 and a loss of $14.3M in the three months ended March 31, 2010.